Apolipoprotein E Genotype Test Kit Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Apolipoprotein E Genotype Test Kit Market Size
The global Apolipoprotein E Genotype Test Kit market was valued at US$ 89 million in 2023 and is anticipated to reach US$ 385.5 million by 2030, witnessing a CAGR of 23.0% during the forecast period 2024-2030.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-3Q8648/Global_and_China_Apolipoprotein_E_Genotype_Test_Kit_Market_Insights_Forecast_to_2027

Apolipoprotein E Genotype Test Kit Market
Apolipoprotein E is an important structural component of particles transporting cholesterol (VLDL, HDL) and is a ligand of cell receptors found mainly in the brain and the liver. The apolipoprotein E gene occurs in three forms of alleles, e2, e3 and e4, which code for protein isoforms E2, E3 and E4 respectively. APOE genotype tests are help understand the role of genetic factors in cardiovascular disease. However, the testing is sometimes used in clinical settings to help confirm a diagnosis of type III hyperlipoproteinemia (also known as familial dysbetalipoproteinemia). The APOE genotype test evaluates a person's DNA to determine what APOE forms (alleles) are present. APOE e3/e3 is the most common genotype (seen in well over half of the population) and is considered "neutral." Risks of disease are made relative to the e3/e3 population. APOE e4 (as e4/e4 and e4/e3) is found in nearly a quarter of the population and is associated with an increased risk of atherosclerosis. The e4 allele of the APOE gene has been widely demonstrated to be associated with increased risk of AD. In individuals with a clinical diagnosis of AD, the presence of the e4 allele increases the likelihood that the diagnosis is correct, but is not diagnostic alone. APOE genotyping is not recommended for predicting AD risk in asymptomatic individuals. In this report, we study Apolipoprotein E Genotype Testing, kit and services are covered. Price is the cost of one test.
Global key players of apolipoprotein e genotype test kit include 23andMe, LabCorp, Empower DX, Mega Genomics, etc. Global top five manufacturers hold a share over 65%. In terms of product, saliva sample is the largest segment, with a share over 77%. And in terms of application, the largest application is online, with a share over 64%.
This report aims to provide a comprehensive presentation of the global market for Apolipoprotein E Genotype Test Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apolipoprotein E Genotype Test Kit.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-3Q8648/Global_and_China_Apolipoprotein_E_Genotype_Test_Kit_Market_Insights_Forecast_to_2027

Segment by Type
• Blood Sample
• Saliva Sample

Segment by Sales Channel
• Online
• Offline

By Company
23andMe, LabCorp, Empower DX, Mega Genomics, Blueprint Genetics, Generi-Biotech, RxHomeTest, Kashi Labs, SolGent, CapitalBio, Genex Diagnostics, Sansure

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-3Q8648/global-and-china-apolipoprotein-e-genotype-test-kit

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.